Results 291 to 300 of about 206,426 (300)

Amyloid beta: structure, biology and structure-based therapeutic development

Acta Pharmacologica Sinica, 2017
Ting-Hai Xu, Karsten Melcher, H Eric Xu
exaly  

Target analysis by integration of transcriptome and ChIP-seq data with BETA

Nature Protocols, 2013
Su Wang, Hanfei Sun, Chongzhi Zang
exaly  

Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial

Lancet, The, 2012
Jeffrey A Cohen, Alasdair J Coles, Douglas L Arnold   +2 more
exaly  

The Amyloid Beta Peptide: A Chemist’s Perspective. Role in Alzheimer’s and Fibrillization

Chemical Reviews, 2012
exaly  

beta 2-glycoprotein I in human and murine atherosclerosis.

The Israel Medical Association journal : IMAJ, 2001
Y, Shoenfeld, Y, Sherer, Y, George, D, Harats   +3 more
openaire   +1 more source

Reduced serum beta 2-glycoprotein I in SLE.

Annals of the rheumatic diseases, 1992
J, Matsuda, M, Tsukamoto, N, Saitoh, K, Gohchi, K, Kawasugi, K, Asami, M, Hashimoto   +6 more
openaire   +1 more source

Tests of the standard electroweak model in nuclear beta decay

Reviews of Modern Physics, 2006
exaly  

[IgG anti-beta 2-glycoprotein I beta 2-glycoprotein I] immune complexes in patients with antiphospholipid (aPL) syndrome

1998
BIASIOLO A, RAMPAZZO P, BROCCO P, ROSATO, ANTONIO, BARBERO F, PENGO, VITTORIO   +5 more
openaire   +1 more source

Anti-beta 2-glycoprotein I antibodies in Sneddon's syndrome.

Dermatology (Basel, Switzerland), 1993
C, Francès, J C, Piette, J P, Viard, A, Tourbah   +3 more
openaire   +1 more source

beta 2-Glycoprotein I phenotypes in chronic schizophrenia.

Biological psychiatry, 1983
openaire   +1 more source